Chimeric antigen receptor T cell therapy has reshaped expectations for treating hematological malignancies and is now ...

Investigators led by Navdeep Chandel, Ph.D., the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and ...

A groundbreaking study published in Research (2025, DOI: 10.34133/research.0545) has elucidated the molecular mechanisms by which protein phosphatase 2A (PP2A) regulates CD8+ T cell-mediated ...

The protein QRICH1 is a recently identified component of a signaling pathway of CD8+ cells, which are T cells that make up the killing machinery of the immune system, says Pomerantz.